Literature DB >> 24028743

Postmortem analysis of cardiovascular deaths in schizophrenia: a 10-year review.

Joanna Sweeting1, Johan Duflou, Christopher Semsarian.   

Abstract

Schizophrenia is a devastating mental disorder, associated with mortality rates up to three times higher than those in the general population. This post-mortem study sought to investigate the causes of death in a consecutive series of schizophrenia cases, with a specific focus on cardiovascular disease and sudden death. A 10-year review of autopsies in schizophrenia related-cases performed at the Department of Forensic Medicine in Sydney, Australia was undertaken. Premorbid clinical and demographic information was recorded, as well as the key pathological findings and final cause of death. From 2003 to 2012, there were 19,478 postmortem examinations performed of which 683 (3.5%) were deaths in people with a history of schizophrenia. In these cases, the mean age at death was 51years (range 18-93years), with 43% in the 41-60year age group. Males comprised 67% of cases. Overall, 62% of cases had a BMI≥25kg/m(2), indicating overweight or obese individuals. The three primary causes of death were "cardiovascular" (23%), "suicide" (20%), and "drug toxicity" (17%). In 11% of cases (n=72), no definitive cause of death was found, the so-called "unexplained" cases. In conclusion, patients with schizophrenia have premature mortality. The major contributing factors include cardiovascular diseases, suicide and drug toxicity. The "unexplained" and frequently sudden deaths may suggest underlying cardiac arrhythmias as a cause of death in a subgroup of schizophrenia patients.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Sudden unexplained death

Mesh:

Year:  2013        PMID: 24028743     DOI: 10.1016/j.schres.2013.08.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 2.  Neurology issues in schizophrenia.

Authors:  Katharina Hüfner; Beatrice Frajo-Apor; Alex Hofer
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

3.  Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting.

Authors:  Sofie Lindgren Christiansen; Christin Løth Hertz; Laura Ferrero-Miliani; Morten Dahl; Peter Ejvin Weeke; Gyda Lolk Ottesen; Rune Frank-Hansen; Henning Bundgaard; Niels Morling
Journal:  Eur J Hum Genet       Date:  2016-09-21       Impact factor: 4.246

4.  IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis.

Authors:  Milica M Borovcanin; Slavica M Janicijevic; Ivan P Jovanovic; Nevena Gajovic; Nebojsa N Arsenijevic; Miodrag L Lukic
Journal:  Front Psychiatry       Date:  2018-06-22       Impact factor: 4.157

5.  Out-of-Hospital Cardiac Arrest in Patients With and Without Psychiatric Disorders: Differences in Use of Coronary Angiography, Coronary Revascularization, and Implantable Cardioverter-Defibrillator and Survival.

Authors:  Carlo Alberto Barcella; Grimur Høgnason Mohr; Kristian Hay Kragholm; Thomas Alexander Gerds; Svend Eggert Jensen; Christoffer Polcwiartek; Mads Wissenberg; Freddy Knudsen Lippert; Christian Torp-Pedersen; Lars Vedel Kessing; Gunnar Hilmar Gislason; Kathrine Bach Søndergaard
Journal:  J Am Heart Assoc       Date:  2019-08-17       Impact factor: 5.501

Review 6.  Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review.

Authors:  Anuj Rastogi; Dylan Viani-Walsh; Shareef Akbari; Nicholas Gall; Fiona Gaughran; John Lally
Journal:  Gen Hosp Psychiatry       Date:  2020-10-06       Impact factor: 3.238

7.  OCT and OCT Angiography Offer New Insights and Opportunities in Schizophrenia Research and Treatment.

Authors:  Kyle M Green; Joy J Choi; Rajeev S Ramchandran; Steven M Silverstein
Journal:  Front Digit Health       Date:  2022-02-18

Review 8.  Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.

Authors:  Petter Andreas Ringen; John A Engh; Astrid B Birkenaes; Ingrid Dieset; Ole A Andreassen
Journal:  Front Psychiatry       Date:  2014-09-26       Impact factor: 4.157

9.  Obstructive sleep apnea: Underestimated risk factor in sudden cardiac death in schizophrenia.

Authors:  Fulvio A Scorza; Carla A Scorza; Esper A Cavalheiro; Sergio Tufik; Monica L Andersen
Journal:  Sleep Sci       Date:  2016-08-17

10.  Predictive factors for hyperglycaemic progression in patients with schizophrenia or bipolar disorder.

Authors:  Ichiro Kusumi; Yuki Arai; Ryo Okubo; Minoru Honda; Yasuhiro Matsuda; Yukihiko Matsuda; Akihiko Tochigi; Yoshiteru Takekita; Hiroyoshi Yamanaka; Keiichi Uemura; Koichi Ito; Kiyoshi Tsuchiya; Jun Yamada; Bunta Yoshimura; Nobuyuki Mitsui; Sigehiro Matsubara; Takayuki Segawa; Nobuyuki Nishi; Yasufumi Sugawara; Yuki Kako; Ikuta Shinkawa; Kaoru Shinohara; Akiko Konishi; Junichi Iga; Naoki Hashimoto; Shinsaku Inomata; Noriko Tsukamoto; Hiroto Ito; Yoichi M Ito; Norihiro Sato
Journal:  BJPsych Open       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.